IDH1 and central nervous system cancer: Various metabolites, such as 2-hydroxyglutarate (2-HG), α- KG antagonist, competitively inhibit the activity of TET enzymes in IDH mutant glioma cells [8], and itaconic acid (ITA) inhibits Tet activity in macrophages after LPS treatment [20].